← Back to All Stocks

Gossamer Bio, Inc. (GOSS) Analysis

Generated on: 2025-07-31 12:34:24 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$1.87
Predicted Price
$1.56
Expected Return
-14.38%
Confidence Score
0.87
RSI (14)
80.51 (sell)
MACD
0.18
Volume
3,898,900
Float Shares
183,746,504
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250

GOSS

Gossamer Bio, Inc.
-14.38%
Price: $1.87
Confidence: 0.87
News
Last updated: 2025-07-31 12:34:24

Technical Analysis

RSI: 80.51 (sell)
MACD: 0.18
Technical Analysis Graph

Risk Analysis

Volatility
82.64%
Max Drawdown
-49.22%
Beta
1.0
Risk Score
72.7

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Gossamer Bio Completes Enrollment for Phase 3 PROSERA Study of PAH Drug Seralutinib
Insider Monkey - 2025-06-24 16:46
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best biotech stocks to invest in now. On June 16, Gossamer Bio announced the completion of enrollment for its global registrational Phase 3 PROSERA Study. The study is evaluating seralutinib in patients with Functional Class II and III PAH. Seralutinib is being jointly developed by Gossamer Bio […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.